Aim and objective The aim of this study was to compare the two types of hysterectomy—abdominal and non-descent vaginal. Materials and methods A randomized prospective trial was conducted which included 400 patients. Two hundred in abdominal hysterectomy (group I) and 200 in non-descent vaginal (group II). The two groups were compared for the various intraoperative and postoperative parameters and data were analyzed. Results Vaginal hysterectomy had a definite advantage in the postoperative period in terms of shorter hospital stay and early mobility of the patient. The postoperative pain was also less with a statistically significant difference (p value 0.0006). Moreover, there were no wound infections in the group II. Conclusion Vaginal hysterectomy should be the preferred route of hysterectomy whenever feasible. The surgery is performed through the vagina and has greater patient satisfaction in the postoperative period. How to cite this article Rana UB, Pathania K, Sharma P. Comparison of Non-descent Vaginal Hysterectomy vs Total Abdominal Hysterectomy. J South Asian Feder Menopause Soc 2020;8(1):46–48.
INTRODUCTIONHypertensive disorders of pregnancy (HDP) are among the main public health issues worldwide. They account for an estimated 10-15% of maternal deaths globally. 1 Among the hypertensive disorders of pregnancy, preeclampsia is most dangerous, occurring in 10% of first pregnancies, and in 20-25% of women with past history of hypertension. Pre-eclampsia is a pregnancy specific syndrome and it affects 2-5% of pregnancies in developed countries and is a major cause of maternal and perinatal mortality and morbidity. 2 The likelihood of developing pre-eclampsia is increased by a number of factors in the maternal history like primigravidae, history of preeclampsia in previous pregnancies, history of preeclampsia in mother or sister, pre-existing diabetes mellitus, multiple gestations, history of chronic hypertension or chronic renal disease, presence of antiphospholipid antibody syndrome. However, screening by maternal history alone would identify only 30% and 20% of cases of early and late PE, respectively. The precise aetiology of pre-eclampsia is still unknown. The development of pre-eclampsia is thought to be a consequence of impaired trophoblastic invasion of the maternal spiral arteries and their conversion from narrow muscular vessels into wide non-muscular channels. In pre-eclampsia and IUGR there is inadequate trophoblastic invasion of spiral arteries which leads to impedance of blood flow in uterine arteries. 4,5 The systemic endothelial ABSTRACT Background: Hypertensive disorders of pregnancy (HDP) are among the main public health issues worldwide. They account for an estimated 10-15% of maternal deaths globally. Among the hypertensive disorders of pregnancy, preeclampsia is most dangerous, occurring in 10% of first pregnancies, and in 20-25% of women with past history of hypertension. The objective of present study is to investigate the association of Doppler derived Indices of uterine artery resistance with composite of PIH/PET. Methods: A prospective follow up observational study, including pregnant women at 11-13+6 weeks of gestation in whom Uterine Artery Resistance measured using Doppler ultrasound. Results: A total of 100 subjects were enrolled, out of which 11 developed pre-eclampsia/ gestational hypertension. All Doppler indices (Resistance Index, Pulsatility Index and Systolic/Diastolic Index) had high specificities and negative predictive values. Conclusions:The potential advantages of early screening of hypertensive disorders and their associated complications may allow investigations or prophylactic interventions before 20 weeks of gestation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.